These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 22286768)
1. The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival. Ursini-Siegel J; Hardy WR; Zheng Y; Ling C; Zuo D; Zhang C; Podmore L; Pawson T; Muller WJ Oncogene; 2012 Nov; 31(48):5038-44. PubMed ID: 22286768 [TBL] [Abstract][Full Text] [Related]
2. The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression. Ahn R; Sabourin V; Ha JR; Cory S; Maric G; Im YK; Hardy WR; Zhao H; Park M; Hallett M; Siegel PM; Pawson T; Ursini-Siegel J Cancer Res; 2013 Jul; 73(14):4521-32. PubMed ID: 23695548 [TBL] [Abstract][Full Text] [Related]
3. Integration of Distinct ShcA Signaling Complexes Promotes Breast Tumor Growth and Tyrosine Kinase Inhibitor Resistance. Ha JR; Ahn R; Smith HW; Sabourin V; Hébert S; Cepeda Cañedo E; Im YK; Kleinman CL; Muller WJ; Ursini-Siegel J Mol Cancer Res; 2018 May; 16(5):894-908. PubMed ID: 29453318 [TBL] [Abstract][Full Text] [Related]
4. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109 [TBL] [Abstract][Full Text] [Related]
5. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis. Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357 [TBL] [Abstract][Full Text] [Related]
6. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells. Audero E; Cascone I; Maniero F; Napione L; Arese M; Lanfrancone L; Bussolino F J Biol Chem; 2004 Mar; 279(13):13224-33. PubMed ID: 14665640 [TBL] [Abstract][Full Text] [Related]
7. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation. Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404 [TBL] [Abstract][Full Text] [Related]
8. The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function. Vanderlaan RD; Hardy WR; Kabir MG; Pasculescu A; Jones N; deTombe PP; Backx PH; Pawson T Circ Res; 2011 Jan; 108(2):184-93. PubMed ID: 21148430 [TBL] [Abstract][Full Text] [Related]
9. The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner. Im YK; La Selva R; Gandin V; Ha JR; Sabourin V; Sonenberg N; Pawson T; Topisirovic I; Ursini-Siegel J Oncogene; 2015 Mar; 34(13):1729-35. PubMed ID: 24837366 [TBL] [Abstract][Full Text] [Related]
10. [Functional roles of phosphotyrosine adaptor Shc in the brain]. Kakizawa S Nihon Yakurigaku Zasshi; 2018; 152(2):84-89. PubMed ID: 30101865 [TBL] [Abstract][Full Text] [Related]
11. ShcA signalling is essential for tumour progression in mouse models of human breast cancer. Ursini-Siegel J; Hardy WR; Zuo D; Lam SH; Sanguin-Gendreau V; Cardiff RD; Pawson T; Muller WJ EMBO J; 2008 Mar; 27(6):910-20. PubMed ID: 18273058 [TBL] [Abstract][Full Text] [Related]
13. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Pelicci G; Dente L; De Giuseppe A; Verducci-Galletti B; Giuli S; Mele S; Vetriani C; Giorgio M; Pandolfi PP; Cesareni G; Pelicci PG Oncogene; 1996 Aug; 13(3):633-41. PubMed ID: 8760305 [TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells. Baumann G; Maier D; Freuler F; Tschopp C; Baudisch K; Wienands J Eur J Immunol; 1994 Aug; 24(8):1799-807. PubMed ID: 7519995 [TBL] [Abstract][Full Text] [Related]
16. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101 [TBL] [Abstract][Full Text] [Related]
17. Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response. Ursini-Siegel J; Cory S; Zuo D; Hardy WR; Rexhepaj E; Lam S; Schade B; Jirstrom K; Bjur E; Piccirillo CA; Denardo D; Coussens LM; Brennan DJ; Gallagher WM; Park M; Pawson T; Hallett M; Muller WJ Cancer Res; 2010 Oct; 70(20):7776-87. PubMed ID: 20924104 [TBL] [Abstract][Full Text] [Related]
18. Differential signaling by adaptor molecules LRP1 and ShcA regulates adipogenesis by the insulin-like growth factor-1 receptor. Woldt E; Matz RL; Terrand J; Mlih M; Gracia C; Foppolo S; Martin S; Bruban V; Ji J; Velot E; Herz J; Boucher P J Biol Chem; 2011 May; 286(19):16775-82. PubMed ID: 21454706 [TBL] [Abstract][Full Text] [Related]
19. The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Lai KM; Pawson T Genes Dev; 2000 May; 14(9):1132-45. PubMed ID: 10809671 [TBL] [Abstract][Full Text] [Related]
20. The ShcA adaptor protein is a critical regulator of breast cancer progression. Ursini-Siegel J; Muller WJ Cell Cycle; 2008 Jul; 7(13):1936-43. PubMed ID: 18604176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]